[2] [5] Clean the injection site with an alcohol swab and allow it to dry completely
A variant in the GIP receptor gene was associated with significantly higher odds of nausea and vomiting but only in patients taking tirzepatide, not semaglutide
Changes in overall health, like new medical conditions or reactions to the drug, can also make it necessary to adjust or stop treatment
However, determining whether GLP-1 therapy is the best choice for someone should be based on a detailed talk with their doctor that includes a complete review of the persons medical history, their health status, and clarity about their long-term treatment goals
If you're taking diabetes pills and still not at your A1C goal, talk to your healthcare provider to see if RYBELSUS is right for you
The FDA investigation into AC and GLP-1 RA drugs reported: The median age for people who developed AC was 55 years old Of the people who developed AC, 53% were female After starting the drug, 47% of patients developed AC within 90 days Cholelithiasis, or gallstones, was also added to the approval label
